Inspire Medical Systems (NASDAQ:INSP) Director Joyce Erony sold 66,568 shares of Inspire Medical Systems stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $55.75, for a total value of $3,711,166.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Joyce Erony also recently made the following trade(s):
- On Wednesday, May 29th, Joyce Erony sold 44,053 shares of Inspire Medical Systems stock. The shares were sold at an average price of $54.27, for a total value of $2,390,756.31.
- On Thursday, May 23rd, Joyce Erony sold 39,379 shares of Inspire Medical Systems stock. The shares were sold at an average price of $54.52, for a total value of $2,146,943.08.
NASDAQ INSP opened at $54.21 on Wednesday. Inspire Medical Systems has a 52 week low of $28.88 and a 52 week high of $64.34.
Several research firms have recently weighed in on INSP. Zacks Investment Research cut Inspire Medical Systems from a “buy” rating to a “hold” rating in a report on Saturday, May 11th. Dougherty & Co started coverage on Inspire Medical Systems in a report on Tuesday, February 5th. They set a “buy” rating and a $64.00 price objective on the stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Columbus Circle Investors lifted its stake in Inspire Medical Systems by 8.0% in the 4th quarter. Columbus Circle Investors now owns 47,127 shares of the company’s stock valued at $1,991,000 after acquiring an additional 3,494 shares in the last quarter. TD Asset Management Inc. bought a new stake in Inspire Medical Systems in the 4th quarter valued at approximately $404,000. Monashee Investment Management LLC bought a new stake in Inspire Medical Systems in the 4th quarter valued at approximately $4,310,000. Teachers Advisors LLC lifted its stake in Inspire Medical Systems by 10.0% in the 3rd quarter. Teachers Advisors LLC now owns 16,461 shares of the company’s stock valued at $693,000 after acquiring an additional 1,497 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. lifted its stake in Inspire Medical Systems by 79.3% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 59,538 shares of the company’s stock valued at $2,515,000 after acquiring an additional 26,325 shares in the last quarter.
COPYRIGHT VIOLATION WARNING: This article was posted by WKRB News and is the property of of WKRB News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.wkrb13.com/2019/06/05/joyce-erony-sells-66568-shares-of-inspire-medical-systems-insp-stock.html.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
See Also: Why is Cost of Capital Important?
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.